These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17478004)

  • 1. Glycemia and inflammatory markers in acute coronary syndrome: association with late post-hospital outcomes.
    Maciel PT; Pellanda LC; Portal VL; Schaan BD
    Diabetes Res Clin Pract; 2007 Nov; 78(2):263-9. PubMed ID: 17478004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of markers of inflammation for the assessment of cardiovascular risk in patients presenting to the emergency department with acute chest pain suggestive of acute coronary syndrome.
    Roy D; Quiles J; Avanzas P; Arroyo-Espliguero R; Sinha M; Kaski JC
    Int J Cardiol; 2006 May; 109(3):317-21. PubMed ID: 16046018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein, interleukin-6, secretory phospholipase A2 group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes.
    Hartford M; Wiklund O; Mattsson Hultén L; Persson A; Karlsson T; Herlitz J; Caidahl K
    J Intern Med; 2007 Nov; 262(5):526-36. PubMed ID: 17908161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Admission glycemia: a predictor of death after acute coronary syndrome in non-diabetic patients?
    Rocha S; Nabais S; Magalhães S; Salgado A; Azevedo P; Marques J; Torres M; Pereira MA; Correia A
    Rev Port Cardiol; 2007 Dec; 26(12):1367-77. PubMed ID: 18338666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study.
    Bogaty P; Boyer L; Simard S; Dauwe F; Dupuis R; Verret B; Huynh T; Bertrand F; Dagenais GR; Brophy JM
    J Am Coll Cardiol; 2008 Jun; 51(24):2339-46. PubMed ID: 18549920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum gamma-glutamyl transferase activity: new high-risk criteria in acute coronary syndrome patients?
    Ulus T; Yildirir A; Sade LE; Temiz A; Polat E; Bozbaş H; Aydinalp A; Eroğlu S; Ozin B; Müderrisoğlu H
    Coron Artery Dis; 2008 Nov; 19(7):489-95. PubMed ID: 18923245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Admission glycemia and markers of inflammation are independent outcome predictors in primary PCI in non-diabetic patients.
    Corrada E; Cappelleri A; Belli G; Genovese S; Barbaro C; Gasparini G; Pagnotta P; Rossi M; Zavalloni D; Presbitero P
    Minerva Cardioangiol; 2008 Oct; 56(5):445-52. PubMed ID: 18813179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values.
    Kilcullen N; Viswanathan K; Das R; Morrell C; Farrin A; Barth JH; Hall AS;
    J Am Coll Cardiol; 2007 Nov; 50(21):2061-7. PubMed ID: 18021874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes.
    Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B
    Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy.
    Bonello L; De Labriolle A; Lemesle G; Steinberg DH; Roy P; Torguson R; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):866-70. PubMed ID: 19198009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of inflammation on adverse cardiovascular events in patients with acute coronary syndromes.
    Fiechter M; Ghadri JR; Jaguszewski M; Siddique A; Vogt S; Haller RB; Halioua R; Handzic A; Kaufmann PA; Corti R; Lüscher TF; Templin C
    J Cardiovasc Med (Hagerstown); 2013 Nov; 14(11):807-14. PubMed ID: 23572059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome.
    LeLeiko RM; Vaccari CS; Sola S; Merchant N; Nagamia SH; Thoenes M; Khan BV
    Am J Cardiol; 2009 Sep; 104(5):638-43. PubMed ID: 19699337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes.
    Omland T; Ueland T; Jansson AM; Persson A; Karlsson T; Smith C; Herlitz J; Aukrust P; Hartford M; Caidahl K
    J Am Coll Cardiol; 2008 Feb; 51(6):627-33. PubMed ID: 18261681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain.
    Brügger-Andersen T; Pönitz V; Kontny F; Staines H; Grundt H; Sagara M; Nilsen DW
    Thromb Haemost; 2009 Sep; 102(3):555-63. PubMed ID: 19718477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study.
    Empana JP; Canoui-Poitrine F; Luc G; Juhan-Vague I; Morange P; Arveiler D; Ferrieres J; Amouyel P; Bingham A; Montaye M; Ruidavets JB; Haas B; Evans A; Ducimetiere P;
    Eur Heart J; 2008 Aug; 29(16):1966-74. PubMed ID: 18621771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of low dose atorvastatin on inflammatory marker levels in patients with acute coronary syndrome and its potential clinical value.
    Lewandowski M; Kornacewicz-Jach Z; Millo B; Zielonka J; Czechowska M; Kaliszczak R; Płońska E; Goracy J; Kaźmierczak J; Naruszewicz M
    Cardiol J; 2008; 15(4):357-64. PubMed ID: 18698545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of macrophage colony stimulating factor levels in acute coronary syndrome.
    Novo G; Assennato P; Caruso M; Turturici C; Balistreri CR; Amoroso GR; Fazio G; Rotolo A; Coppola G; Hoffmann E; Caruso C; Novo S
    Minerva Cardioangiol; 2009 Feb; 57(1):7-11. PubMed ID: 19202515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.